10-Hydroxycamptothecin
CAS No. 19685-09-7
10-Hydroxycamptothecin ( ChEMBL 273862; NSC 107124 )
Catalog No. M13084 CAS No. 19685-09-7
(S)-10-Hydroxycamptothecin is a clinical therapy agent against hepatoma.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 40 | In Stock |
|
50MG | 54 | In Stock |
|
100MG | 76 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name10-Hydroxycamptothecin
-
NoteResearch use only, not for human use.
-
Brief Description(S)-10-Hydroxycamptothecin is a clinical therapy agent against hepatoma.
-
Description(S)-10-Hydroxycamptothecin is a clinical therapy agent against hepatoma.
-
SynonymsChEMBL 273862; NSC 107124
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopo I
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number19685-09-7
-
Formula Weight364.36
-
Molecular FormulaC20H16N2O5
-
Purity>98%(HPLC)
-
SolubilityDMSO: 8 mg/mL warmed (21.95 mM)
-
SMILESO=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=CC(O)=CC=C5N=C4C3=C2)=O
-
Chemical Name(S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Teicher BA. Biochem Pharmacol. 2007 Oct 22;.
molnova catalog
related products
-
Topovale
Topovale is a potent inhibitor of topoisomerase I. Topovale inhibits hypoxia-mediated accumulation of hypoxia-inducible factor-1alpha.
-
Idarubicin
Idarubicin (4-Demethoxydaunorubicin;IMI-30;NSC 256439) is an anthracycline antileukemic that inserts into DNA and prevents DNA unwinding by interfering with the enzyme Topoisomerase II in cancer cells.
-
GW842166X
GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2.